For the Inventor, By the Inventor

Enter assignee name

Immunwork Inc.

USPTO Granted Patents = 12

EPO Patents = 2

Trademarks = 3

Forward Citations = 2

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Tse-Wen Chang (12 out of 21 patents)

Hsing-Mao Chu (12 out of 18 patents)

Wei-Ting Tian (4 out of 4 patents)

4. Yueh-Hsiang Yu (2 out of 2 patents)

5. Chien-Jen Lin (2 out of 6 patents)

6. Chun-Yu Lin (2 out of 13 patents)

7. Ting-Wei Chang (1 out of 1 patent)

8. Ming-Yu Hsieh (1 out of 1 patent)

9. Li-Yun Du (1 out of 1 patent)

10. Jou-Han Chen (0 patent)

12 patents: Sort by Forward Citations

1. 11926678 - Composite polypeptide having a metal binding motif and molecular construct comprising the same (2024-03-12),

2. 11235064 - Core constructs and their uses in configuring pharmaceutical molecules (2022-02-01),

3. 11220680 - Polypeptide for treating pathological blood clots (2022-01-11),

4. 11203614 - Composite polypeptide having a metal binding motif and molecular construct comprising the same (2021-12-21),

5. 10993986 - Pharmaceutical constructs with enhanced binding affinity with albumin (2021-05-04),

6. 10894091 - Linker units and molecular constructs comprising the same (2021-01-19),

7. 10668165 - Molecular constructs for treating tumors (2020-06-02),

8. 10442861 - Molecular constructs with targeting and effector moieties for treating infectious diseases (2019-10-15),

9. 10383947 - Pharmaceuticals in joint-linker configurations for treating pathological blood clots (2019-08-20),

10. 10300104 - Multi-arm linker for treating rejection reaction in transplantation (2019-05-28),

11. 10293018 - Fusion protein for treating rejection reaction in transplantation (2019-05-21),

12. 10202455 - Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod (2019-02-12),

Immunwork Inc. is a biotechnology company focused on developing innovative immunotherapy solutions for a variety of diseases. Our proprietary technology platform allows us to create personalized treatment options for patients, leading to improved outcomes and quality of life. With a team of experienced researchers and scientists, we are dedicated to advancing the field of immunotherapy and improving patient care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#333 in Taipei

#1,241 in Taiwan

#48,090 in the World

Immunwork Inc.

Forward Citations = 2

9 inventors:

Tse-Wen Chang (12 out of 21 patents)

Hsing-Mao Chu (12 out of 18 patents)

Wei-Ting Tian (4 out of 4 patents)

4. Yueh-Hsiang Yu (2 out of 2 patents)

5. Chien-Jen Lin (2 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…